Nanhua Futures (603093.SH) Overseas subsidiary has obtained relevant membership qualifications.
Nanhua Futures (603093.SH) announced that its wholly-owned overseas subsidiary, NANHUA SINGAPORE PTE. LTD., has received notifications from ICE Futures Singapore (IFSG) and ICE Clear Singapore (ICSG) recently, being approved as a trading member of IFSG and a clearing member of ICSG, allowing it to trade and clear products listed on IFSG.
Nanhua Futures (603093.SH) announced recently that its overseas wholly-owned subsidiary, NANHUA SINGAPORE PTE. LTD., has received notifications from ICE Futures Singapore (IFSG) and ICE Clear Singapore (ICSG) that it has been approved to become a trading member of IFSG and a clearing member of ICSG, allowing it to trade and clear products listed on IFSG.
Related Articles
CARDIOFLOW-B (02160) has issued approximately 3.954 billion shares of bonus shares.
LIVZON PHARMA (01513): NS-041 tablet has obtained drug clinical trial approval notice for the new indication of treating depression.
QINGDAO PORT (06198) plans to invest 6.615 billion yuan to construct the Dongjiakou general wharf project.
CARDIOFLOW-B (02160) has issued approximately 3.954 billion shares of bonus shares.
LIVZON PHARMA (01513): NS-041 tablet has obtained drug clinical trial approval notice for the new indication of treating depression.
QINGDAO PORT (06198) plans to invest 6.615 billion yuan to construct the Dongjiakou general wharf project.
